Get started

LUPIN

Lupin : Bullish Breakout Coming Soon ?!Lupin has been consolidating for last few sessions and a directional breakout is expected very soon and if it happens to upside, we can see some good 50 points run on the trade. Yes, I'm expecting it but on Bearish breakout also you can take the trade, The thing about consolidation & ranging is many think that predicting direction is right approach. NO. Let Market decide direction & we go with the flow, that's right approach, if false breakout we will reverse the trade. Happy Trading !
NSE:LUPINLong
by InsiderB
8
LUPIN BUY (LONG)Lupin is a BUY at CMP@1470 with SL@1420 for a target of TP@1600 Lupin gets USFDA nod to market pain relief, colonoscopy drugs and also gets FDA approval for generic Percocet tablets . Lupin recently received FDA approval for generic Suprep Bowel Prep Kit and Suprep kit approval It may add 5% to Lupin’s EPS for FY18 earnings. In addition the pharma major’s Goa facility has been cleared by the US FDA. Lupin Result: Revenue grew 26% YoY to INR 44.8b Gross margin was stable QoQ at 71.0%. EBITDA rose 27% YoY to INR 12.2b with margin of 27% . EBITDA margin improvement was primarily driven by strong growth in US sales (+53% YoY, +8% QoQ; despite R&D as % of sales at 12.9%) and forex gain of INR 270m. PAT of INR 6.3b was impacted by 1% due to a high tax rate of 39%. Lupin is a BUY at CMP@1470 with SL@1420 for a target of TP@1600
NSE:LUPINLong
by VIRUSSOUL